Sangamo Therapeutics (SGMO) Shares Stabilize Amid Recent Key Pipeline Update

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) is 1 of the stocks nether $1 that volition explode.

Sangamo Therapeutics, Inc.’s (NASDAQ:SGMO) stock terms has underperformed implicit the past year, down astir 64%. However, by the clip the marketplace opened connected January 9, 2026, the banal had recorded a 7.19% stock terms summation implicit the erstwhile 5 sessions.

This caller stabilization successful the banal is somewhat supported by a caller cardinal pipeline update that refocused capitalist attraction connected the company’s pb cistron therapy program.

On December 18, 2025, Sangamo Therapeutics, Inc. (NASDAQ:SGMO) announced the initiation of a rolling Biologics License Application (BLA) submission to the U.S. Food and Drug Administration. The institution is seeking accelerated support of isaralgagene civaparvovec (ST-920) for adults with Fabry disease, with the submission allowing completed modules to beryllium reviewed connected an ongoing basis. It volition perchance shorten the regulatory timeline up of a afloat filing expected successful Q2 2026.

The information from the registration STAAR survey enactment the BLA, arsenic it demonstrated ST-920’s imaginable arsenic a one-time, durable cistron therapy. Importantly, the FDA validated the assertion that the mean annualized eGFR slope astatine 52 weeks tin service arsenic the accelerated support endpoint, arsenic dosed patients showed a affirmative slope indicative of kidney relation stabilization. The regulatory momentum is soaring high, with ST-920 besides carrying Orphan Drug, Fast Track, and RMAT designations.

Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a clinical-stage biotech company, develops genomic medicines crossed inherited metabolic, neurologic, and immune diseases. The institution leverages cistron therapy and genome engineering platforms to prosecute durable, perchance curative treatments.

While we admit the imaginable of SGMO arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 7 Best Rising Tech Stocks to Buy Now and 12 Best Multibagger Stocks to Buy Heading into 2026.

Disclosure: None.